🤖 AI Summary
Wearable health technologies increasingly blur the regulatory boundary between “wellness” and “medical” devices, with many over-the-counter products operating on non-clinically validated data and frequently deployed off-label in clinical settings—posing safety risks, exacerbating health inequities, and undermining public trust. This paper proposes an adaptive regulatory framework centered on distributed risk assessment, patient-centered outcome orientation, and incremental institutional evolution to overcome the limitations of static device classification. Employing a mixed-methods approach—including legal text analysis, cross-jurisdictional case studies, and ethical impact assessment—the study systematically identifies critical gaps in current regulatory regimes and designs a dynamic, technology-institution co-evolutionary pathway. The framework advances theoretical innovation in governance design and delivers actionable policy recommendations for building a pluralistic, resilient, and equitable regulatory ecosystem for wearable health technologies—thereby enhancing safety, inclusivity, and societal acceptability.
📝 Abstract
As wearable health technologies have grown more sophisticated, the distinction between "wellness" and "medical" devices has become increasingly blurred. While some features undergo formal U.S. Food and Drug Administration (FDA) review, many over-the-counter tools operate in a regulatory grey zone, leveraging health-related data and outputs without clinical validation. Further complicating the issue is the widespread repurposing of wellness devices for medical uses, which can introduce safety risks beyond the reach of current oversight. Drawing on legal analysis, case studies, and ethical considerations, we propose an approach emphasizing distributed risk, patient-centered outcomes, and iterative reform. Without a more pluralistic and evolving framework, the promise of wearable health technology risks being undermined by growing inequities, misuse, and eroded public trust.